Search
Filter Results
- Resource Type
- Article1
- Book1
- Book Digital1
- Article Type
- Review1
- Result From
- Lane Catalog1
- PubMed1
-
Year
- Journal Title
- Diabetes1
Search Results
Sort by
- BookDave Anderson.Summary: Helping you uncover your potential and upgrade your performance to become the best, this the inspiring framework illustrates its straightforward explanations with dozens of personal accounts from leaders across numerous industries, including business, media, sports, and more.
Contents:
Introduction
The undertaker
The caretaker
The playmaker
The game changer
It's about decisions, not conditions
The wonder of why
Live your life in the zone
Go A.P.E
The key to mental toughness
Create your unstoppable philosophy
Develop a daily mindset discipline
The unfathomable power of example
Epilogue.Digital Access ProQuest Ebook Central [2017]Limited to 1 simultaneous users - ArticleBinder C, Faber OK.Diabetes. 1978;27 Suppl 1:226-9.Improvement in the sensitivity and specificity of the C-peptide immunoassay and studies of larger groups of patients have increased our knowledge of the importance of residual beta-cell function and its metabolic consequences in insulin-treated diabetic patients. During the first five to 10 years after the onset of diabetes mellitus residual beta-cell function is demonstrable in the majority of insulin-treated patients irrespective of the severity of the initial symptoms and only partly dependent on the patient's age at diagnosis. Residual beta-cell function facilitates good control. Stable patients have a higher C-peptide concentration in plasma than unstable ones, but unmeasurable C-peptide is not always associated with poor control. More data are needed before the full significance of an even minimal reserve of beta-cell function is elucidated. It also remains to be shown whether the reductive in beta-cell function in diabetic patients has a qualitative as well as quantitative component.